CARRIE FERNALD: Open Payments
NPI 1912172081 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,437 in 76 payments from 13 companies in 2025. Trend: 2023 $90 · 2024 $152 · 2025 $1,437
Food & beverage: $1,437
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $566 |
| Collegium Pharmaceutical, Inc. | 12 | $201 |
| PFIZER INC. | 15 | $182 |
| AstraZeneca Pharmaceuticals LP | 2 | $119 |
| Novo Nordisk Inc | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $59 |
| Lilly USA, LLC | 3 | $49 |
| Astellas Pharma US Inc | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Orexo US, Inc. | 2 | $35 |
Products named: QULIPTA, Belbuca, NURTEC ODT, UBRELVY, AIRSUPRA, Wegovy, VRAYLAR, TRINTELLIX.
Industry payments across NC — which companies pay providers there.
